ISSCR News


Human Biology, Better Medicines: Advancing iPSC-Based Models for Discovery and Development
Message from the President Kym Kilbourne Message from the President Kym Kilbourne

Human Biology, Better Medicines: Advancing iPSC-Based Models for Discovery and Development

Induced pluripotent stem cell (iPSC) technology has transformed biomedicine far beyond its original promise for regenerative medicine. By preserving a patient’s genetic background while enabling the generation of disease-relevant cell types—and increasingly sophisticated tissue architectures such as organoids and other advanced in vitro systems—we can now recreate key aspects of human pathology in the laboratory. These platforms are becoming a powerful engine not only for mechanistic disease research, but also for drug discovery and development.

Read More
New Podcast Episode. Making Sense of Touch
Announcements Megan Koch Announcements Megan Koch

New Podcast Episode. Making Sense of Touch

Merkel cells are specialized touch-sensing cells in the skin that detect gentle pressure and support fine motor skills. They are sparsely distributed in the basal layer of the epidermis and are concentrated in sensitive areas such as whiskers or fingertips. Despite their important function, our understanding of their development is limited, particularly in humans, largely due to the lack of validated in vitro culture systems. Our guests today created new lab models to study Merkel cells using mouse whisker tissue cultures, mouse skin organoids, and human skin organoids. These models allowed them to study Merkel cells as they develop, validate the role of known signaling pathways, and even identify some new ones. Their work provides easier access to Merkel cells for future studies including disease models to understand the pathophysiology of these cells.  

Read More
Member Spotlight: Maike Sander, MD
Member Spotlight Hunter Reed Member Spotlight Hunter Reed

Member Spotlight: Maike Sander, MD

ISSCR provides an unparalleled global community and evolving standards that bring together scientific excellence, ethical leadership, and collaboration. I value the society’s role in educating patients and convening international dialogue at conferences and symposiums.

Read More
Cloaked Stem Cells Evade Immune Rejection in Mice, Pointing to a Potential Universal Donor Cell Line
Press Release Kym Kilbourne Press Release Kym Kilbourne

Cloaked Stem Cells Evade Immune Rejection in Mice, Pointing to a Potential Universal Donor Cell Line

study published today in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can overcome immune rejection in mice with humanized immune systems, surviving for five months in a stringent transplantation model. The findings provide proof-of-principle for the development of a potential universal donor hPSC line designed to resist immune attack.

Read More

Receive ISSCR Press Releases

Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications

Subscribe to ISSCR News.

Each month, ISSCR delivers scientific, policy, and community to your inbox .